was successfully added to your cart.

Cart

Introducing IDDT – the InDependent Diabetes Trust

VibraTip®

Category: Latest News

Knowing that nerves in your feet are damaged is vitally important – because this puts your feet at a higher risk of injury and requires you to be much more meticulous in your footcare.

Prof. Andrew Levy, at Bristol University Hospital NHS Foundation Trust, has invented a clever tool that helps to quickly and easily identify an early sign of a problem with the feet – the inability of the nerves to distinguish between a touch and a vibration – the VibraTip®, a small battery operated device, emits a calibrated vibration when squeezed. Only the operator knows when the VibraTip® is active because the device runs silently. If the patient cannot distinguish between a touch with vibration and a touch without vibration at the end of the big toe, nerve damage is suspected and further tests and advice are needed. Click here to read more

The simplicity of the test also allows a family member or friend to check patients’ feet at home, looking for those early signs of any loss in protective nerve function.

A VibraTip® costs only £14.30 and can be ordered from the IDDT Shop or by phoning IDDT on 01604 622837. Each device is individually blister-packed and can be used thousands of times before it needs replacing.

Be aware of high strength insulins

Category: Latest News

Several new insulins have come to the market recently; three high strength insulins which have concentrations greater than the previously standard strength of U100 and biosimilar insulin.

The Trustees of IDDT have discussed the introduction of different strengths of insulin in depth and strongly expressed their concerns about the risks of errors by people with diabetes, health professionals and hospitals. These concerns come from their experiences of the introduction of the first genetically modified human insulin in the 1980s when there was a dearth of evidence of benefit and many people with diabetes were not informed of the differences from their previous natural animal insulin.

Click here to read more

Warning – review of three Type 2 drugs

Category: Latest News

The European Medicines Agency (EMA) has started a review of canagliflozin, dapagliflozin and empagliflozin, which are diabetes medicines known as SGLT2 inhibitors. This was requested by the European Commission following several reports of diabetic ketoacidosis in patients on SGLT2 inhibitor treatment for Type 2 diabetes. EMA will now review all available data on the risk of diabetic ketoacidosis (DKA) with SGLT2 inhibitors and consider whether any changes are needed in the way these medicines are used in the EU.

Click here to read more

Diabetes – Parents Passport For Schools

Category: Latest News

The InDependent Diabetes Trust [IDDT] is all too aware of the difficulties that children with diabetes and their parents face in everyday life when managing the condition. One area that proves particularly problematic is managing the condition at school. With this in mind, IDDT has produced a new, FREE booklet, the Parents Passport for Schools.

Click here to read more

Too many Children with diabetes not getting the care they need

Too many children and young people with diabetes not getting the care they need

Category: Latest News

The National Paediatric Audit report by the Royal College of Paediatrics and Child Health, March 2015, has shown that in England and Wales only 16.1% of young people aged 12 years and older are receiving the 7 annual checks that every child with diabetes should have. This is a slight improvement from the last audit but still very worrying.

Click here to read more

First ever mandatory care standards to improve the level of care of children and young people with diabetes

Young diabetics ‘get worse care’

Category: Latest News

There is an urgent need for effective public health strategies to deal with diabetes, starting with more consistent NHS testing, says Jenny Hirst, Chair of the InDependent Diabetes Trust (IDDT).

Click here to read more.

InDependent Diabetes Trust